Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

@article{Pu2005DualsubtypeFV,
  title={Dual-subtype FIV vaccine (Fel-O-Vax{\textregistered} FIV) protection against a heterologous subtype B FIV isolate},
  author={Ruiyu Pu and James K. Coleman and James G Coisman and Eiji Sato and Taishi Tanabe and Maki Arai and Janet K. Yamamoto},
  journal={Journal of Feline Medicine and Surgery},
  year={2005},
  volume={7},
  pages={65 - 70}
}

Figures from this paper

Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
TLDR
Findings from these studies are being used to define the prophylactic epitopes needed for an HIV-1 vaccine for humans.
Vaccine protection against feline immunodeficiency virus: setting the challenge.
TLDR
The challenges facing vaccine development, the current state of knowledge and future prospects for FIV vaccination are reviewed.
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan.
TLDR
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection was conducted in Japan and a geographic distribution of four subtypes (A, B, C and D) of FIV in Japan was disclosed.
Limited efficacy of an inactivated feline immunodeficiency virus vaccine
TLDR
The vaccine is licensed in the USA, Canada and Australia for use in cats over eight weeks of age, and has been shown to provide protection against a number of FIV isolates, including those of subtypes A, B and C.
Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
TLDR
This data indicates that FIV infection in cats is a natural infection of domestic felid populations which results in a chronic and progressive acquired immunodeficiency syndrome and that vaccination against FIV is a viable treatment option for these patients.
Sequence variation of the feline immunodeficiency virus genome and its clinical relevance
TLDR
It is important that the key determinants of immunity induced by this vaccine are discovered; such data would compliment vaccine field efficacy studies and provide the basis to make informed recommendations on its use.
...
...

References

SHOWING 1-10 OF 20 REFERENCES
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
TLDR
Dual-subtype vaccinated cats developed broad-spectrum humoral and cellular immunity which protected cats against in vivo-derived inocula of homologous and heterologous FIV subtypes, suggesting an increase in cytotoxic cell activities against AIDS viruses.
FIV vaccine development and its importance to veterinary and human medicine: a review
Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
TLDR
The results of the present study are discussed in the light of enhancement of lentiv virus infections as a complicating factor in lentivirus vaccine development.
Enhancement after feline immunodeficiency virus vaccination.
Vaccination with Inactivated Virus but Not Viral DNA Reduces Virus Load following Challenge with a Heterologous and Virulent Isolate of Feline Immunodeficiency Virus
TLDR
Results indicate that the more virulent FIVGL8 is intrinsically more resistant to vaccinal immunity than the FIVPET strain and that a broad spectrum of responses which includes virus neutralizing antibodies is a desirable goal for lentivirus vaccine development.
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades
TLDR
Analysis of all available FIV env sequences revealed the existence of recombinant viruses generated from subtype A/B, B/D, and A/C envelope gene sequences, consistent with the hypothesis that Fiv-B is an older virus group and is possibly more host adapted than FIV-A.
Feline bone marrow transplantation: its use in FIV-infected cats.
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
  • M. Kimura
  • Biology
    Journal of Molecular Evolution
  • 2005
TLDR
Some examples were worked out using reported globin sequences to show that synonymous substitutions occur at much higher rates than amino acid-altering substitutions in evolution.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
TLDR
The neighbor-joining method and Sattath and Tversky's method are shown to be generally better than the other methods for reconstructing phylogenetic trees from evolutionary distance data.
...
...